Interim Measures for the Administration of Advertising Examination with Three Products and One Machine

The Interim Measures for the Administration of Three Products and One Machine Advertisement Examination is an important regulation of drug advertisement examination management in China, which clarifies the procedures, contents and standards of advertisement examination and strengthens the supervision of drug advertisements.

The Interim Measures for the Examination and Management of Three Products and One Machine Advertisement is an important regulation for the examination and management of drug advertisements in China. This method clarifies the procedures, contents and standards of advertisement examination, strengthens the supervision of drug advertisements, and aims to standardize drug advertisements and ensure public health and safety. Specifically, the measures stipulate the examination procedures of drug advertisements, including declaration, preliminary examination, review and audit. At the same time, it also stipulates the guidelines and standards that drug advertisements should abide by, including not containing false, exaggerated and misleading contents, and not misleading consumers by means of medical knowledge and celebrity endorsements. In addition, the measures also increase the monitoring and handling mechanism after drug advertisements are released, and severely deal with illegal advertisements. Generally speaking, the implementation of the Interim Measures for the Examination and Management of Three Products and One Machine Advertisement has strengthened the supervision of drug advertisements, guaranteed public health and safety, and is of great significance to standardizing market order and promoting the benign development of the pharmaceutical industry.

What drug is "three products and one device" mentioned in the Interim Measures for the Administration of Advertising Examination of Three Products and One Device? The "three products and one product" mentioned in the Interim Measures for the Administration of Advertising Examination with Three Products and One Product refers to vaccines, blood products, in vitro diagnostic reagents and medical devices. These drugs are high-risk and high-tech products, which have an important impact on the health and safety of consumers, so strict advertising review management is needed.

The implementation of the Interim Measures for the Examination and Management of Three Products and One Machine Advertisement has standardized drug advertising, strengthened drug advertising supervision and ensured public health and safety. At the same time, this method also improves the technical threshold of drug advertisement declaration, promotes the benign development of the pharmaceutical industry, and is of great significance to promoting the development of the pharmaceutical industry.

Legal basis:

Article 6 of the Interim Measures for the Administration of Advertising Examination with Three Products and One Machine, if medical terms or words such as diseases, symptoms, causes, treatment methods and effects, celebrity endorsements, recommended treatment, etc. are used in advertisements, the following requirements shall be met: (1) Explain the scope of indications of drugs; (2) Description of the main components, performance, manufacturer, production batch number and expiration date of the drug; (three) clearly explain the adverse reactions, contraindications and precautions of drugs; (four) shall not contain false, exaggerated propaganda, misleading content.